Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares OutstandingShort-Term Debt repayments
Ratios

HeartSciences (HSCS) Shares Outstanding (2021 - 2026)

HeartSciences filings provide 6 years of Shares Outstanding readings, the most recent being $536767.0 for Q1 2026.

  • On a quarterly basis, Shares Outstanding fell 48.0% to $536767.0 in Q1 2026 year-over-year; TTM through Jan 2026 was $536767.0, a 48.0% decrease, with the full-year FY2025 number at $1.1 million, up 194.16% from a year prior.
  • Shares Outstanding hit $3.2 million in Q1 2026 for HeartSciences, up from $3.1 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $8.3 million in Q1 2023 to a low of $10000.0 in Q1 2022.
  • Median Shares Outstanding over the past 5 years was $927118.5 (2024), compared with a mean of $2.4 million.
  • The widest YoY moves for Shares Outstanding: up 3708.71% in 2023, down 98.63% in 2023.
  • HeartSciences' Shares Outstanding stood at $8.2 million in 2022, then plummeted by 98.63% to $112286.0 in 2023, then soared by 744.11% to $947821.0 in 2024, then plummeted by 59.86% to $380440.0 in 2025, then skyrocketed by 41.09% to $536767.0 in 2026.
  • The last three reported values for Shares Outstanding were $536767.0 (Q1 2026), $380440.0 (Q4 2025), and $429901.0 (Q3 2025) per Business Quant data.